84477-93-0 Usage
Description
(2-AMINO-2-PHENYL-ETHYL)-CARBAMIC ACID BENZYL ESTER is a chemical compound with the molecular formula C16H17N3O2. It is a carbamic acid ester with a benzyl group attached to the nitrogen atom, which contributes to its unique structural features and functional groups.
Used in Pharmaceutical Research:
(2-AMINO-2-PHENYL-ETHYL)-CARBAMIC ACID BENZYL ESTER is used as a building block in organic synthesis and pharmaceutical research for the synthesis of various drugs and bioactive molecules. Its structural features and functional groups make it a promising candidate for the development of new drugs.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (2-AMINO-2-PHENYL-ETHYL)-CARBAMIC ACID BENZYL ESTER is used as a key intermediate for the preparation of various pharmaceutical compounds. Its potential applications in drug development highlight its importance in creating new therapeutic options.
Used in Agrochemical Compounds:
(2-AMINO-2-PHENYL-ETHYL)-CARBAMIC ACID BENZYL ESTER also serves as a key intermediate in the preparation of various agrochemical compounds, indicating its versatility and applicability in different fields beyond pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 84477-93-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,4,7 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 84477-93:
(7*8)+(6*4)+(5*4)+(4*7)+(3*7)+(2*9)+(1*3)=170
170 % 10 = 0
So 84477-93-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H18N2O2/c17-15(14-9-5-2-6-10-14)11-18-16(19)20-12-13-7-3-1-4-8-13/h1-10,15H,11-12,17H2,(H,18,19)
84477-93-0Relevant articles and documents
ROCK-INHIBITING COMPOUND AND USES THEREOF
-
, (2020/05/07)
Disclosed herein are a compound of formula (I) and a preparation method and uses thereof. The compound shows a good inhibitory activity against ROCK, providing a new medicinal strategy to clinically treat the diseases associated with abnormal ROCK activity.
